...
首页> 外文期刊>Medicinal research reviews >Dual DNA topoisomerase 1 and tyrosyl‐DNA phosphodiesterase 1 inhibition for improved anticancer activity
【24h】

Dual DNA topoisomerase 1 and tyrosyl‐DNA phosphodiesterase 1 inhibition for improved anticancer activity

机译:双DNA拓扑异构酶1和酪氨酸-DNA磷酸二酯酶1改善抗癌活性的抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Tyrosyl‐DNA phosphodiesterase 1 (Tdp1) is a DNA repair enzyme that catalyzes the hydrolysis of the phosphodiester bond in the DNA‐topoisomerase 1 (Top1) covalent complex and repairs some other 3′‐end DNA adducts. Currently, Tdp1 functions as an important target in cancer drug design owing to its ability to break down various DNA adducts induced by chemotherapeutics. Tdp1 inhibitors may sensitize tumor cells to the action of Top1 poisons, thereby potentiating their effects. This mini‐review summarizes findings from studies reporting the combined inhibition of Top1 and Tdp1. Two different approaches have been considered for developing such drug precursors.
机译:摘要酪氨酸-DNA磷酸二酯酶1(TDP1)是一种DNA修复酶,其催化DNA-己二异素酶1(TOP1)共价复合物中的磷酸二酯键的水解并修理其他3'-末端的DNA加合物。 目前,由于其分解化学治疗剂诱导的各种DNA加合物,TDP1作为癌症药物设计的重要目标。 TDP1抑制剂可以使肿瘤细胞敏感到TOP1 POISON的作用,从而提高它们的效果。 这种迷你审查总结了报告对TOP1和TDP1的合并抑制的研究的研究结果。 已经考虑了两种不同的方法来开发这种药物前体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号